These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 1350604)

  • 21. [Comparative studies of antimicrobial agents against causative organisms isolated from urinary tract infections (1983). I. Susceptibility distribution].
    Kosakai N; Igari J; Kumamoto Y; Sakai S; Shigeta S; Shiraiwa Y; Abe K; Tazaki H; Iri H; Uchida H
    Jpn J Antibiot; 1985 Aug; 38(8):2185-229. PubMed ID: 4079003
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Microbiology of diabetic foot infections in a teaching hospital in Malaysia: a retrospective study of 194 cases.
    Raja NS
    J Microbiol Immunol Infect; 2007 Feb; 40(1):39-44. PubMed ID: 17332905
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Update on antimicrobial susceptibility rates among gram-negative and gram-positive organisms in the United States: results from the Tigecycline Evaluation and Surveillance Trial (TEST) 2005 to 2007.
    Dowzicky MJ; Park CH
    Clin Ther; 2008 Nov; 30(11):2040-50. PubMed ID: 19108792
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Multicentre survey of the comparative in-vitro activity of piperacillin/tazobactam against bacteria from hospitalized patients in the British Isles.
    Chen HY; Bonfiglio G; Allen M; Piper D; Edwardson T; McVey D; Livermore DM
    J Antimicrob Chemother; 1993 Aug; 32(2):247-66. PubMed ID: 8226427
    [TBL] [Abstract][Full Text] [Related]  

  • 25. In vitro activity of SCH-34343, a new penam, and other antimicrobial agents against clinical isolates from cancer patients.
    Rolston KV; Alvarez ME; Hoy JF; Alderman HC; Ho DH; Bodey GP
    Chemotherapy; 1986; 32(6):506-14. PubMed ID: 3100147
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Antimicrobial activity of imipenem against 1386 clinical isolates.
    Belobraydic KA; Qadri SM
    Methods Find Exp Clin Pharmacol; 1986 Nov; 8(11):675-8. PubMed ID: 3468319
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Multicenter study to assess the in vitro activity of tigecycline by disk diffusion test against clinical isolates from Argentina.
    Fernández Canigia L; Kaufman S; Lanata L; Vay C; Giovanakis M; Bantar C;
    Chemotherapy; 2009; 55(1):20-7. PubMed ID: 18974645
    [TBL] [Abstract][Full Text] [Related]  

  • 28. In vitro activity profile of ceftobiprole, an anti-MRSA cephalosporin, against recent gram-positive and gram-negative isolates of European origin.
    Pillar CM; Aranza MK; Shah D; Sahm DF
    J Antimicrob Chemother; 2008 Mar; 61(3):595-602. PubMed ID: 18218646
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Monitoring of antibiotic resistance in bacterial isolates from bacteremic patients.
    Blahová J; Králiková K; Krcméry V; Babálová M; Menkyna R; Glosová L; Knotková H; Lisková A; Molokácová M; Vaculíková A
    J Chemother; 2004 Jun; 16(3):269-72. PubMed ID: 15330324
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Antibacterial activities of monobactams against fresh clinical isolates].
    Deguchi K; Yokota N; Koguchi M; Nakane Y; Fukayama S; Nishimura Y; Oda S; Tanaka S; Kato M; Sato K
    Jpn J Antibiot; 1988 Nov; 41(11):1600-22. PubMed ID: 3210297
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Bacterial isolates from severe infections and their antibiotic susceptibility patterns in Italy: a nationwide study in the hospital setting.
    Nicoletti G; Schito G; Fadda G; Boros S; Nicolosi D; Marchese A; Spanu T; Pantosti A; Monaco M; Rezza G; Cassone A; Garaci E;
    J Chemother; 2006 Dec; 18(6):589-602. PubMed ID: 17267336
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Frequency of isolation and antimicrobial susceptibility of bacteria isolated from bloodstream infections at Children's Medical Center, Tehran, Iran, 1996-2000.
    Mamishi S; Pourakbari B; Ashtiani MH; Hashemi FB
    Int J Antimicrob Agents; 2005 Nov; 26(5):373-9. PubMed ID: 16213124
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Analysis of resistance tendency of bloodstream-infecting pathogens in China].
    Lü Y; Li Y; Xue F; Zhang XZ; Hu YJ; Jin YF; Chu YZ; Hu ZD; Zhao JH; Pan SY; Zhao WS; Hu BJ; Yu YS; Deng QL; Yang J; Li Y; Liu WE; Lü XJ; Yang YJ; Zhou L; Dong F; Fu WL; Xu XL; Pei FY; Yang B; Meng L; Ji P; Wang S
    Zhonghua Jie He He Hu Xi Za Zhi; 2013 Jun; 36(6):411-9. PubMed ID: 24103203
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Epidemiology and susceptibility profile of blood culture isolates in an intensive care unit (2002-2005)].
    Elouennass M; Sahnoun I; Zrara A; Bajjou T; Elhamzaoui S
    Med Mal Infect; 2008 Jan; 38(1):18-24. PubMed ID: 18065180
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Comparative studies of antimicrobial agents against causative organisms isolated from urinary tract infections (1983). II. Background of patients].
    Kosakai N; Igari J; Kumamoto Y; Sakai S; Shigeta S; Shiraiwa Y; Abe K; Tazaki H; Iri H; Uchida H
    Jpn J Antibiot; 1985 Aug; 38(8):2230-41. PubMed ID: 4079004
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Antibacterial effect of imipenem in vitro against important aerobic and anaerobic strains isolated from clinical specimens.
    Klietmann W; Focht J; Nösner K
    Chemioterapia; 1987 Aug; 6(4):243-50. PubMed ID: 3477332
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Community acquired bacterial infections and their antimicrobial susceptibility in Nairobi, Kenya.
    Malonza IM; Omari MA; Bwayo JJ; Mwatha AK; Mutere AN; Murage EM; Ndinya-Achola JO
    East Afr Med J; 1997 Mar; 74(3):166-70. PubMed ID: 9185414
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Potency and spectrum of tigecycline tested against an international collection of bacterial pathogens associated with skin and soft tissue infections (2000-2004).
    Fritsche TR; Sader HS; Stilwell MG; Dowzicky MJ; Jones RN
    Diagn Microbiol Infect Dis; 2005 Jul; 52(3):195-201. PubMed ID: 16105564
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [The antibacterial activity of fluoroquinolones against gram-negative bacteria isolated from Gifu Prefecture (2005)].
    Tanaka T; Mitsuyama J; Yamaoka K; Asano Y; Hashido H; Matsukawa Y; Matsubara S; Sawamura H; Suematsu H; Terachi M; Miyabe T; Mikamo H; Watanabe K;
    Jpn J Antibiot; 2007 Jun; 60(3):141-52. PubMed ID: 17867488
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Nationwide surveillance of parenteral antibiotics containing meropenem activities against clinically isolated strains in 2006].
    Yamaguchi K; Ishii Y; Iwata M; Watanabe N; Uehara N; Yasujima M; Kasai T; Suwabe A; Yamahata K; Kaku M; Kanemitsu K; Imafuku Y; Nishiyama K; Murakami M; Yomoda S; Taniguchi N; Yamada T; Nomura F; Watanabe M; Kanno H; Aihara M; Maesaki S; Hashikita G; Kondo S; Misawa S; Horiuchi H; Tazawa Y; Nakashima H; Takemura H; Okada M; Yamazaki F; Horii T; Maekawa M; Baba H; Ishigo S; Fujita N; Komori T; Ichiyama S; Iinuma Y; Maeda S; Yamanaka K; Murata Y; Matsuo S; Kohno H; Kinoshita S; Fujita J; Negayama K; Murase M; Miyamoto H; Kusano N; Mihara E; Itaha H; Ono J; Yoshimura H; Yanagihara K; Matsuda J; Saikawa T; Hiramatsu K
    Jpn J Antibiot; 2007 Dec; 60(6):344-77. PubMed ID: 18447206
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.